Related Experiment Video
Updated: Aug 6, 2026
06:03
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Small cell lung cancer 1973-1983: early progress and recent obstacles
Summary
Systemic chemotherapy significantly improved survival for small cell lung cancer patients starting in the 1970s. Recent therapeutic advances have slowed, prompting a review of current and future treatment strategies.
Area of Science:
- Oncology
- Medical Sciences
- Cancer Research
Background:
- Small cell lung cancer (SCLC) is predominantly diagnosed at a metastatic stage.
- Systemic chemotherapy led to major survival improvements for SCLC patients in the 1970s.
- The pace of therapeutic advancement in SCLC has decelerated in recent years.
Purpose of the Study:
- To review recently evaluated treatment strategies for small cell lung cancer.
- To summarize advances in understanding SCLC cell biology for future therapeutic development.
Main Methods:
- Review of recently evaluated treatment strategies for small cell lung cancer.
- Discussion of intensive induction chemotherapy, late intensive therapy, and regimen alternation.
- Evaluation of integrated chest irradiation with chemotherapy and large field irradiation.
- Reappraisal of the role of surgical resection in SCLC management.
- Summary of cell biology insights relevant to novel SCLC treatments.
Main Results:
- Several treatment strategies have been recently evaluated, including intensified chemotherapy regimens and combined modality approaches.
- The review critically assesses the value of surgery and discusses the integration of radiation therapy with chemotherapy.
- Progress in understanding SCLC cell biology is highlighted as a foundation for future therapies.
Conclusions:
- While initial chemotherapy regimens dramatically improved SCLC survival, recent progress has plateaued.
- Current research focuses on refining existing treatments and exploring novel therapeutic targets based on SCLC cell biology.
- A comprehensive review of treatment strategies is essential for guiding future clinical practice and research in SCLC.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...